Terminated OBSERVATIONAL NCT00005295

Idiopathic Pulmonary Fibrosis: a Case-control Study

Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Conditions Lung Diseases Lung Diseases, Interstitial Pulmonary Fibrosis

Updated 7 times since 2017 Last updated: Mar 9, 2024 Started: Jul 31, 1989 Completion: Jun 30, 1995

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Not a clinical Trial \& inadvertently entered in the system.

Other terminated trials from National Heart, Lung, and Blood Institute (NHLBI)

See all terminations from National Heart, Lung, and Blood Institute (NHLBI)

Other Lung Diseases trials with similar outcome

Browse all Lung Diseases trials

This observational or N/A phase trial investigates Lung Diseases and Lung Diseases, Interstitial and is currently terminated or withdrawn. National Heart, Lung, and Blood Institute (NHLBI) leads this study, which shows 7 recorded versions since 1989 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Terminated
Jul 2024 — Sep 2024 [monthly]

Terminated
Apr 2024 — Jul 2024 [monthly]

Terminated

Status: Completed → Terminated
Jan 2021 — Apr 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed

▶ Show 2 earlier versions

Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Completed NA

First recorded

Jul 1989

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Heart, Lung, and Blood Institute (NHLBI)
University of New Mexico

Data source: University of New Mexico

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.